Search for: "Teva Pharmaceuticals USA, Inc."
Results 161 - 180
of 489
Sort by Relevance
|
Sort by Date
8 Jun 2017, 3:27 am
Teva Pharmaceuticals USA, Inc., the Federal Circuit had its first opportunity to address the impact of the “or otherwise available to the public” clause contained in post-AIA 35 U.S.C. [read post]
28 May 2017, 8:19 pm
Biosig Instruments, Inc. and Teva Pharmaceuticals USA, Inc. v. [read post]
25 May 2017, 6:20 pm
Sandoz, Inc., 749 F. [read post]
4 May 2017, 8:26 am
(“Helsinn”) brought suit against Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries, Ltd. [read post]
4 May 2017, 8:26 am
(“Helsinn”) brought suit against Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries, Ltd. [read post]
1 May 2017, 12:44 pm
Teva Pharmaceuticals USA, Inc., the Federal Circuit panel of Judges Dyk, Mayer and O’Malley determined: “after the AIA, if the […] The post CAFC Interprets AIA On-Sale Bar: Invention details need not be public for sale to be invalidating appeared first on... [read post]
12 Apr 2017, 10:32 am
Defendants are Actavis LLC of Parsippany, New Jersey; Teva Pharmaceuticals USA, Inc. of North Wales, Pennsylvania; and Teva Pharmaceutical Industries, Ltd. of Petach Tikva, Israel. [read post]
12 Apr 2017, 10:32 am
Defendants are Actavis LLC of Parsippany, New Jersey; Teva Pharmaceuticals USA, Inc. of North Wales, Pennsylvania; and Teva Pharmaceutical Industries, Ltd. of Petach Tikva, Israel. [read post]
12 Apr 2017, 7:13 am
Teva Pharmaceuticals USA, Inc. et al, 2-15-cv-01455 (TXED April 10, 2017, Order) (Bryson, CJ) [read post]
6 Apr 2017, 1:35 pm
USA,Inc., 731 F.3d 1271, 1279 (Fed. [read post]
3 Apr 2017, 9:59 pm
Teva Pharmaceuticals USA, Inc. v. [read post]
8 Mar 2017, 8:03 pm
Because we see no error in these rulings, we affirmthe district court’s entry of judgment against Sprint.Teva gets cited as to "claim construction":The proper construction of a patent’s claims is an issueof Federal Circuit law, and we apply the frameworkset forth in Teva Pharmaceuticals USA, Inc. v. [read post]
10 Feb 2017, 10:52 am
February 8, 2017), the Court granted defendant Teva Pharmaceuticals USA, Inc. [read post]
8 Feb 2017, 3:09 am
Teva Pharmaceuticals USA, Inc., et al. [read post]
16 Jan 2017, 5:44 pm
Teva Pharmaceuticals USA, Inc., et al. [read post]
12 Jan 2017, 12:42 pm
;Teva Pharmaceuticals USA, Inc.; and Barr Laboratories,Inc. [read post]
9 Jan 2017, 9:36 am
In other words, Copaxone should remain a $4 billion drug, annually.link to Pantagraph: http://www.pantagraph.com/business/investment/markets-and-stocks/factors-that-sent-teva-pharmaceutical-industries-ltd-sliding-in/article_74234eee-a5ec-5c58-a54b-82597151b1e6.htmlPatents covering "three per week" dosing were not at issue in the Supreme Court case of Teva Pharmaceuticals USA, Inc. v. [read post]
19 Nov 2016, 4:48 am
Teva Pharmaceuticals USA, Inc., Civil Action No. 14-874-SLR (D.Del., November 16, 2016), the Court found the asserted claims of U.S. [read post]
14 Nov 2016, 9:16 am
Teva Pharmaceuticals USA, Inc., et al. [read post]
13 Oct 2016, 6:50 am
Teva Pharmaceuticals USA, Inc., et al. [read post]
